Cargando…
Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study
BACKGROUND: The purpose of this observational study was to evaluate feasibility, efficacy results and toxicity observations of capecitabine in routine first line treatment of patients with metastatic colorectal cancer, with particular regard of elderly patients (>75 years of age). METHODS: Patien...
Autores principales: | Stein, Alexander, Quidde, Julia, Schröder, Jan Klaus, Göhler, Thomas, Tschechne, Barbara, Valdix, Annette-Rosel, Höffkes, Heinz-Gert, Schirrmacher-Memmel, Silke, Wohlfarth, Tim, Hinke, Axel, Engelen, Andreas, Arnold, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750193/ https://www.ncbi.nlm.nih.gov/pubmed/26865161 http://dx.doi.org/10.1186/s12885-016-2113-8 |
Ejemplares similares
-
Clinical Management of Localized Colon Cancer with Capecitabine
por: Quidde, J., et al.
Publicado: (2012) -
Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results
por: Hofheinz, Ralf, et al.
Publicado: (2014) -
Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial
por: Stein, Alexander, et al.
Publicado: (2013) -
The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective study
por: Michie, C O, et al.
Publicado: (2010) -
Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study
por: Creutzfeldt, Anna, et al.
Publicado: (2016)